CONTROLLED DRUGS LOCAL INTELLIGENCE NETWORK (LIN)

1 Role

1.1 The purpose of the Controlled Drugs Intelligence Network (LIN) will be to share information and intelligence regarding the management and use of controlled drugs which are prescribed, dispensed, administered, stored or destroyed in the areas covered by Fife NHS Board.

1.2 The network will cover all hospitals, healthcare premises, care homes; NHS Fife

employed staff and independent contractors in the area of Fife and Fife Council.

2 Remit 2.1 The LIN will provide a forum for regular communication between members. 2.2 Consider local information and intelligence on management and use of controlled

drugs. 2.3 Enable concerns about the activities of any healthcare professional or organisation to

be shared as soon as possible with any other local agencies who might be affected or who may have complementary information about the issue.

2.4 To agree and maintain information-sharing protocols.

2.5 Constitute incident panels as appropriate.

3 Reporting and responsible arrangements

3.1 Subgroup of the NHS Fife Area Drug & Therapeutics Committee (ADTC) . Six monthly governance reports to be provided to the ADTC and the NHS Fife Clinical Governance Committee.

4 Links

Fife ADTC NHS Fife Clinical Governance Committee

5 Membership 5.1 Accountable Officer – Controlled Drugs and Director of Pharmacy (Deputy Chair)

Chair Fife Area Pharmaceutical Committee Chair of the GP Sub-Committee Chief Pharmacist -Acute Services Division Counter Fraud Liaison Officer Director of Nursing -Acute Services Division Fife Chair, Scottish Care General Pharmaceutical Council Inspector for the Fife region Lead Pharmacist for - Controlled Drugs Medical Director (Chair) NHS Fife Community Lead Safety Officer Representation from Police Scotland P division Representative of The Fife Addictions Service Representative of the Fife Alcohol and Drug Partnership Social Work representative

5.2 The Chair will be the Medical Director for NHS Fife and Deputy Chair will be the Accountable Officer / Director of Pharmacy.

5.3 The Chair will also be available to act on intelligence passed on by the network when

the Accountable Officer is unavailable. 5.4 The quorum for the Local Intelligence Network will be a minimum of six members

including the Chair or Deputy Chair. 5.5 Managers or other relevant persons may be invited to attend to provide additional

information on a particular agenda item. 5.6 All members of the Local Intelligence Network, their deputies and other attendees are

bound by an agreement of confidentiality based on the Caldicott Principles to enable the sharing of identifiable information where this is essential, in the assured knowledge that named information or sources will not be revealed outside the network. All members with access to information provided through the Fife Local Intelligence Network for Controlled Drugs, has a responsibility when accessing this information to adhere to the requirements of the Information Sharing Protocol (appendix A) and to all relevant legislation, policy, procedures and guidelines.

6 Frequency of meetings 6.1 The Controlled Drugs Local Intelligence Network will meet every six months. 6.2 The Accountable Officer or Medical Director for NHS Fife may agree to hold

extraordinary meetings for the network should an issue arise necessitating such. Date approved by Local Intelligence Network: June 2015

Date approved by Clinical Governance Commitee: Review date June 2017

Scottish Accord on the

Sharing of Personal Information

Local Intelligence Network (LIN) for Controlled Drugs

Information Sharing Protocol

Version: 1

Content

Part A – Introduction to this ISP………………………………………………………… 4

1 Scope and purpose of this ISP………………………………………………......... 4

2 High level functions of this ISP……….…………………………………………… 5

3 Service Users included in this ISP………………………………………………... 5

4 Benefits to Service Users…………………………………………………………... 5

5 Details of personal information being shared………………………………….. 5

6 Key identifying information………………………………………………………… 6

7 The information sharing partner organisations …………………………….….. 6

Part B – Justification for sharing personal information……………………………… 8

8 Legislative/statutory powers………………………………………………………... 8

9 Consent………………………………………………………………………………... 9

Part C – Operational procedures for this ISP…………………………………………… 10

10 Summary………………………………………………………………………………. 10

11 Fair processing information……………………………………………………….. 10

12 Obtaining consent…………………………………………………………………… 10

13 Sharing information without consent…………………………………….……. 11

14 Action to be taken where subject lack capacity…………..……………….. 12

15 Temporary impairment of capacity………………………………………………. 12

16 Information collection………………………………………………………………. 12

17 Frequency of information sharing……………………………………………….. 13

18 Retention Schedules……………………………………………………………….… 13

19 Subject Access Rights ……………………………………………………………… 13

20 Information Security ………………………………………………………………….. 13

21 Complaints …………….……………………………………………………………. 13

22 Review of this ISP……………………………………………………………………. 13

Part D – Methods and controls for the sharing of personal information to support this ISP…………………………………………………………….…… 14

23 Information Flow Process …………………………………….……….…………... 14

24 Annex A Information which can be shared …………..………………….….….… 15

25 Annex A Contact Details of Accountable Officer, Controlled Drugs …..….… 15

26 Annex B Information Flow Process Chart ………………….…...………………. 16

27 Annex C Govt Protected Marking Scheme Guidance …………………….…….. 17

28 Annex D Police Scotland P division Information/Intelligence Sharing Report …..…. 18

29 Annex E Confidentiality Statement………………………………………………….19

Part A – Introduction to this ISP

1 Scope and purpose of this ISP

1.1 This Information Sharing Protocol (ISP) is supplementary to the Scottish Accord on the Sharing of Personal Information (SASPI), and has been agreed between the participating partner organisations. Partners have given consideration to its contents when drawing up this document.

1.2 UK Health Act 2006 and the Controlled Drugs (Supervision of Management and Use) Regulations 2006 place a statutory duty of co-operation on responsible bodies to share information and intelligence about the management and use of controlled drugs.

1.3 The 2006 Regulations require the NHS Board Accountable Officer for Controlled Drugs to establish a Local Intelligence Network (LIN) for sharing information regarding the management and use of controlled drugs. LIN enables responsible bodies to share concerns through appropriate channels about professional or organisational activities around the management and use of controlled drugs.

1.4 This ISP has been prepared to support the regular sharing of information for the management and safety of controlled drugs , some of which may be personal information

1.5 It supports the information sharing partner organisations involved and the groups of Service Users it impacts upon. It details the specific purposes for sharing and the personal information being shared, the required operational procedures, consent processes, and legal justification. The partner organisations that are party to this agreement are committed to enable data to be shared in a manner that is compliant with their statutory responsibilities.

• Ensure effective information management of data relating to controlled drugs

• Promote partnership working

• Provide assurance of compliance with current information legislation including Data Protection Act and other relevant legislation and guidelines i.e. Caldicott Guidelines

1.6 This Information Sharing Protocol covers the exchange of information between: NHS Fife

• Police Scotland P Division

• Fife Council

• NHS Scotland Counter Fraud Services

• Professional Regulatory Bodies

• Care inspectorate For the purpose of supporting data sharing and enabling responsible bodies to share concerns through appropriate channels about professional or organisational activities around the management and use of controlled drugs.

1.7 This information may also be shared to support the effective administration, audit, monitoring, inspection of services and reporting requirements. Partner organisations may only use the information disclosed to them under this ISP for the specific purpose(s) set out in this document.

2 High level functions of this ISP

2.1 The functions which this information sharing protocol community are seeking to support involve:

• Facilitating the exchange of information between partners

• Review or analysis of trends in CD use

• Interpretation of CD data in relation to local influences

• Identification of persons or groups of people who are managing, using, prescribing or handling CDs inappropriately

• Identifying “best practice” in the management of CDs

• Identifying poor systems of control for the management of CDs

• Raising concerns relating to any of the above.

2.2 Personal information shared to support functions other than those detailed above are not supported by this ISP.

3 Service Users included in this ISP

3.1 The Service Users which this ISP relates to include:

• Any individual, whether or not healthcare professional, who is involved in any way (NHS or private) with the management or use of controlled drugs

4 Benefits to Service Users

4.1 Benefits to the Service Users include:

• Strengthen and improve governance arrangements on the management of CD’s

• Promote the safe and effective use of CD’s across Fife

5 Details of personal information being shared

5.1 Personal information shared for the purpose of this ISP includes a range of information regarding the Service Users needs.

5.2 The information shared might therefore include:

• Incidents involving controlled drugs

• Concerns regarding any aspect of the management and use of controlled drugs

• Intelligence on controlled drug issues in accordance with the 5x5x5 handling code See Annex D

Any of the above may include confidential details of relevant individuals involved, including health or social care professionals, staff members, patients, carers or other members of the public.

5.3 The information is used to inform detailed discussions within the core LIN or a Controlled Drug Incident Panel.

5.4 Only the minimum necessary personal information consistent with the purposes set out in this document must be shared.

5.5 The data and information will only be accessed by a restricted number of personnel who will have been made aware of the confidential nature of the data and information.

5.6 Not all LIN members will be entitled to receive information as it will be strictly on a ‘need to know’ basis.

5.7 Strictly on a case by case basis, there may a requirement for information to be shared without the consent of the data subject.

5.8 Confidential information about persons will be anonymised unless this is

inappropriate, otherwise patient/carer consent will be sought wherever practicable and/or appropriate.

5.9 Where information is supplied by a person who is not an employee, each organisation will make secure arrangements for the holding and access to such information.

6 Key identifying information

6.1 When sharing information, the following identifiers will be used where available, to ensure that all partners are referring to the same Service User:

• Name

• Address

• Contact details

• Gender

• DOB

• CHI number

• Job title, job base/location

7 The information sharing partner organisations

7.1 This ISP covers the exchange of information between staff of the following organisations that are engaged in delivering the service outlined in this document:

Information Sharing Partner Organisations Responsible Manager

NHS Fife Police Scotland P division Fife Council

Accountable Officer for Controlled Drugs

Police Liaison Officer Team Manager, Residential,

Day & Home Care Services

NHS Scotland Counter Fraud Services Professional Regulatory Bodies Care inspectorate

Senior Investigator Intelligence & Proactive Team

Inspector General Pharmaceutical Council

Care Inspectorate Officers

7.2 The responsible managers detailed above have overall responsibility for this ISP within their own organisations, and must therefore ensure the ISP is disseminated, understood and acted upon by relevant staff.

7.3 Staff of these partner organisations who work directly with Service Users in order to carry out the functions described in this ISP, are bound by this document.

7.4 The term ‘staff’ encompasses paid workers, volunteers, students and other temporary workers approved by the employing / hosting organisation, whose duties include those relating to the functions outlined in this ISP.

7.5 Partner organisations will ensure that all current and newly-appointed staff receive appropriate training in the application of this ISP and the requirements of the SASPI framework.

7.6 Every clinician, practitioner, or any other individual with access to information provided through the Fife Local Intelligence Network for Controlled Drugs, has a responsibility when accessing this information to adhere to the requirements of this Information Sharing Protocol and to all relevant legislation, policy, procedures and guidelines.

Part B – Justification for sharing personal information

Please note: Staff should not hesitate to share personal information in order to prevent abuse or serious harm, in an emergency or in life-or-death

situations. If there are concerns relating to child or adult protection issues, the relevant organisational procedures must be followed.

8 Legislative / statutory powers

8.1 Disclosure of information will be conducted within the legal framework of the Data Protection Act 1998 (DPA), the Human Rights Act 1998 and in compliance with the common law duty of confidence.

8.2 Disclosure of information will also be conducted in line with additional powers provided to partners undertaking statutory duties in the sharing of information including:

• UK Health Act (2006)

• Controlled Drugs (Supervision of management and use) Regulations 2006

• Misuse of Drugs Act 1971

• Misuse of drugs regulations 2001

• The Freedom on Information (Scotland) Act 2002

• Caldicott Principles

8.3 This protocol has been drawn up taking into account the following guidance � Safer Management of Controlled Drugs: Guidance on Strengthened Governance

Arrangements HDL (2007) 12 � Information Sharing between NHS Scotland and the Police, CEL 13 (2008) � Accountable Officers/the Association of Chief Police Officers in Scotland

(ACPOS) – Working Protocol for reporting suspected criminal activity in relation to controlled drugs

� NHS Scotland Counter Fraud Services Partnership Agreement with Health Boards

� Memorandum of Understanding between Human Resources Teams of NHS Scotland and NHS Scotland Counter Fraud Services

� Memorandum of Understanding between the Association of Chief Police Officers in Scotland (ACPOS) and NHS Scotland Counter Fraud Services

� The Management of Police Information – Partnership Version

� Caldicott Guidelines & Principles

9 Consent

9.1 Consent is normally required to share information between different partner organisations. To provide valid informed consent the Service Users or their lawful representatives, must be provided with appropriate information to enable them to make an informed decision.

9.2 For the purposes of this ISP, no consent will be required from Service Users.

9.3 Implied consent is given when a Service User takes some action, including making a judgement, in the knowledge that in doing so he or she has incidentally agreed to a particular use or disclosure of information.

9.4 Explicit consent is given by a Service User agreeing actively, either verbally or in writing, to a particular use or disclosure of information. It can be expressed either verbally or in writing, although written consent is preferable since that reduces the scope for subsequent dispute.

9.5 Consent must not be secured through coercion or inferred from a lack of response to a request for explicit consent. The Practitioner must be satisfied that the Service User has understood the information sharing arrangements and the consequences of providing or withholding consent.

9.6 Consent should not be regarded as a permanent state. Opportunities to review the Service User’s continuing consent to information sharing should arise during the course of the service provision. The Practitioners should exercise professional judgement in determining whether it would be appropriate to re-visit a Service User’s continued consent at any given juncture. Ideally it should take place in the context of a review or re-assessment.

Part C – Operational procedures for this ISP

10 Summary

10.1 Only the minimum necessary personal information will be shared on a need-to-know basis and only when it supports the delivery of the purposes and functions set out in this ISP.

10.2 Personal information will only be collected using the approved collection methods, ensuring the required information is complete and up-to-date.

10.3 All reasonable steps must be taken to ensure that anyone who has received information is notified of any relevant changes and if any inaccuracies are found the necessary amendments will be made.

10.4 Decisions about Service Users should never be made by referring to inaccurate, incomplete or out-of-date information.

10.5 Information provided by partner organisations will not be released to any third party without the permission of the owning partner organisation.

10.6 Staff must also follow their own organisation’s procedures relating to the handling of personal information.

Please note: Staff should not hesitate to share personal information in order to prevent abuse or serious harm, in an emergency or in life-or-death

situations. If there are concerns relating to child or adult protection issues, the relevant organisational procedures must be followed.

11 Fair processing information

11.1 It is necessary to communicate with the Service User or their lawful representatives about the need for information sharing at the earliest appropriate opportunity, preferably at first contact.

11.2 Being clear and open with Service Users about how their personal information will be used, will allow them to make an informed decision regarding consent for the sharing of their information.

11.3 Partner organisations will clearly inform the Service Users about what personal information is to be shared, who the information will be shared between, why it needs to be shared and for what purposes it will be used for.

11.4 Agreed methods of providing this information are: • NHS Fife Fair Processing Notice

• Fife Council Privacy Policy

• Police Scotland P Division

12 Obtaining consent

12.1 The approach to obtaining consent should be transparent and respect the Service User.

12.2 For the purposes of this ISP, no consent will be required from Service Users.

12.3 Information will be shared in order to prevent abuse or serious harm and strictly in accordance with Controlled Drugs (Supervision of Management and Use) Regulations, 2006 regs. 25 -28

12.4 Partner organisations should be prepared to be open with their Service Users about the role that their consent plays in the information sharing process and indeed be clear about the type of circumstances in which they may share personal information without their knowledge or consent.

12.5 If there is a significant change in the use to which the information will be used compared to that which had previously been explained, or a change in the relationship between a partner organisation and the Service User, then consent will be sought again.

12.6 Consent obtained from Service User’s for the purposes of this ISP will only be used to support the delivery of the purposes and functions set out in this document. Once the service provision of this specific ISP concludes, then consent obtained will also end. In the event of a similar or subsequent service provision undertaken in the future, new consent will be obtained.

12.7 Staff should use opportunities such as reviews or assessments to reaffirm the Service User’s consent to the sharing of information outlined in this ISP.

13 Sharing information without consent

13.1 Staff are permitted to disclose personal information without consent in order to prevent abuse or serious harm to others. If there are concerns relating to child or adult protection issues, staff must follow the relevant local procedures of their partner organisation.

13.2 Personal information can be lawfully shared without consent where there is a legal requirement or where an appropriate professional of sufficient seniority within the partner organisation, has taken the view that the duty of confidentiality can be breached in exceptional circumstances and where there is a substantial over-riding ‘public interest’. Such situations where information might be shared without consent include:

• ‘Life and death’ situations, for example, where information is shared in an emergency in order to preserve life;

• where a person’s condition indicates they may be a risk to the public or may inflict self-harm;

• in order to prevent abuse or serious harm to others;

• on a case-by-case basis, to prevent serious crime and support detection, investigation and punishment of serious crime.

• within the healthcare setting, the ‘appropriate professional’ is the Caldicott Guardian whose prior approval must be sought to share personal information without consent in the exceptional circumstances as outlined above.

This is not an exhaustive list.

13.3 If a claim of substantial public interest is made, justification will be clearly stated and any decision to share information with another party without the consent of the Service User will be fully documented in the Service user’s personnel file by the appropriate organisation. This note will include details of the legal requirement used or details of the relevant senior professional who authorised the sharing.

13.4 The Service User will usually be informed of this decision and of the information which has been shared; unless by doing so it would risk harm to others or hinder any investigation or legal proceedings.

14 Actions to be taken where a Service User lacks capacity

14.1 Whenever dealing with issues of capacity to consent, local rules and procedures should be followed and these must be compatible with the Adults with Incapacity (Scotland) Act 2000 and its associated guidance.

15 Temporary impairment of capacity

15.1 Where a person has a temporary loss of capacity, consent will be deferred, if appropriate, until such time as consent can be obtained. Consent to share information will be sought when capacity is regained.

15.2 Where it is not appropriate to defer the sharing of information, then it will not be appropriate to defer consent, as consent cannot be obtained retrospectively. Therefore, only where deemed necessary, may information be shared without consent, see section 16 above for further information.

16 Information collection

16.1 The approved collection tools for partner organisations to gather the personal information detailed in this ISP are:

� Information will be shared and recorded strictly in accordance with regulations 25 to 28 of the Controlled Drugs (Supervision of Management and Use) Regulations 2006

� Information shared between LIN members will only be circulated electronically between secure email addresses. The relevant organisation’s e-mail use policy must be followed. (Secure e-mail addresses are pnn, gsi, gsx, nhs.net and cjsm.net).

� Where secure e-mail does not exist the sharing will either be in hard copy, to named individuals, marked ‘In Confidence’, or will be tabled at the meeting. Confidential information about individuals will only be shared on a strict need to know basis.

� No Police information with a protective marking above ‘Restricted’ will be shared. � Information will only be shared by fax in cases of operational urgency. In these

circumstances the person sending the fax must telephone the recipient who will wait by their fax machine. The covering page will then be sent and once the recipient has confirmed receipt, the remainder of the fax can be sent.

� Verbal requests will only be dealt with when urgent. In such a case, the person making the request and the person receiving it will record, at the time of the request

� the name and designation of the person to whom the information was given or from whom it was received

� details of the information given or received � the purpose for which it was given or received � the time, date and place the information was given or received � Any decision not to disclose information following a verbal request will also be

recorded

All verbal requests will be followed with a request and response in writing. The request will be issued immediately following the verbal request if it has not already been sent. This will be by secure e mail or hard copy.

17 Frequency of information sharing

17.1 The personal information outlined within Section 5, Part D and Annex A, will only be shared on a need-to-know basis to support the functions of this ISP.

17.2 Partner organisations will share relevant personal information as required.

17.3 Should changes be made to a record, all reasonable efforts must be taken to ensure that anyone who has received a copy of the record is also alerted to the change.

18 Retention Schedules

18.1 Personal data will be held, processed and then destroyed securely in accordance with the retention schedule of each partner organisation.

19 Subject Access Requests

19.1 Requests for personal information will be processed and responded to using the standard SAR procedure within each partner organisation.

20 Information Security

20.1 Breaches of security, confidentiality and other violations of this ISP must be reported in line with each partner organisations’ incident reporting procedures.

20.2 Significant data breaches involving personal information provided by partners under this ISP should be notified to the partner that originally provided the information.

21 Complaints

21.1 Each partner organisation has a formal procedure by which Service Users can direct, their complaints regarding the application of this ISP.

22 Review of this ISP

22.1 This ISP will be reviewed on every 2 years or sooner if appropriate.

Part D – Methods and controls for the sharing of personal information to support this ISP

23 Information flow process

23.1 The sharing of information may be triggered during the course of an investigation or an incident or concern where it is clear that another body may be affected or have information which may assist the investigation.

23.2 Where several partners are involved, the NHS Fife Accountable Officer for Controlled Drugs may establish a Controlled Drug Incident Panel of relevant partners or individuals to consider specific serious concerns. Membership of the panel will depend on the nature of the concern or incident, but will include members of the LIN.

23.3 Each partner will retain responsibility for taking appropriate action where required. Action may include the further investigation of issues of concern or the initiation of processes to protect the safety of the public. If patient safety is thought to be at risk immediate action.

23.4 The Information Flow Chart (see Annex B) provides a list of the personal information to be shared between the partner organisations, with whom in each partner organisation it will be shared with, when it will be shared, why it will be shared and the methods of how it will be shared.

23.5 The information flow reference table will be reviewed and updated as necessary, to reflect any changes in the processing of personal information detailed in this ISP.

Annex A – Information which can be shared under this ISP

24 Details of information to be shared

24.1 Demographics and other identifiers

• Name

• Address

• Contact Details

• Gender

• DOB

• CHI number

• Job title, job base/location

24.2 Additional information including:

• Incidents involving controlled drugs

• Concerns regarding any aspect of the management and use of controlled drugs

• Intelligence on controlled drug issues

Any of the above may include confidential details of relevant individuals involve, including health or social care professionals, staff members, patients, carers or other members of the public.

25 Contact Details of the Accountable Office for Controlled Drugs

The Accountable Officer for controlled drugs can be contacted in confidence at

Fife-uhb.cd@nhs.net or 01383 565 351 Pharmacy Services Pentland House Lynebank Hospital Halbeath Road Dunfermline KY11 4UW

26. Annexe B

GOVERNMENT PROTECTIVE MARKING SCHEME GUIDANCE The Government Protective Marking Scheme (GPMS) sets out five levels of Protective Marking that can be applied to the information handled (referred to as assets), depending on the degree of sensitivity involved. The majority of information held within the Police Service contains personal or sensitive personal data and therefore requires a Protective Marking. (Information already in the public domain will not require protective marking). The levels of Protective Marking are as follows: PROTECT, RESTRICTED, CONFIDENTIAL, SECRET, TOP SECRET When a protective marking is applied to an information asset it is indicating its impact in terms of the damage that is likely to result from that information being compromised. The sections on this page detail the criteria specific to public order, public safety and law enforcement pertinent to RESTRICTED and CONFIDENTIAL. The originator of any information is responsible for deciding the appropriate classification to be applied. No one can alter or amend a classification other than the originator. When selecting the appropriate marking, consideration needs to be given to how damaging the consequences would be if that material were lost, stolen, disclosed or destroyed. This guidance is intended to give a very basic appreciation of the application of protective markings to police information together with guidance on handling, movement, storage and disposal requirements.

CLASSIFICATION RESTRICTED CONFIDENTIAL MARKING Top & bottom of every page

Pages numbered Top & bottom of every page Pages numbered

STORAGE OF PAPERS Protected by ONE barrier (locked container/drawer)

Protected by TWO barriers (locked container within locked room

PHOTOCOPYING Stamped with Classification and marked COPY

Authority of Originator stamped with Classification

DISPOSAL OF PAPERS Confidential waste sack Secure when unattended

Tear by hand, place within confidential waste sack or cross cut shredder. Secure when unattended.

DISPOSAL OF MAGNETIC MEDIA

Overwrite with approved software utility. Securely destroy. Dismantle, cut into quarters. Normal waste

Overwrite with approved software utility. Securely destroy. Dismantle, cut into quarters Normal waste.

MOVEMENT WITH GREAT BRITAIN, BY POST

Post or Courier Service Sealed Envelope No marking on envelope

Post or Courier Service Double sealed envelope. Inner stamped CONFIDENTIAL Return address outer

MOBILE TELEPHONE Digital Cell Phones only Only if operationally URGENT. Guarded speech. Brief conversation.

INTERNET Government approved encryption required.

Not to be used

FAX/EMAIL Check recipient able to receive. Send Cover Sheet first. Wait confirmation before sending.

Secure fax only Government approved encryption required.

Annex C

GPMS RESTRICTED WHEN COMPLETE

POLICE SCOTLAND P DIVISION

INFORMATION / INTELLIGENCE SHARING REPORT

(Non law enforcement

OFFICER

(Name/Rank No)

DATE/TIME OF

REPORT

RECEIVING

AGENCY

REPORT U.R.N.

EVALUATION A

Always Rel iable

B

Mostly Rel iable

C

Sometimes

Rel iable

D

Unrel iable

E

Untes ted Source

INFORMATION

VALUE

1

Known to be true

without

res ervation

2

Known

pers onal ly to

source but not to

the officer

3

Not known

persona l ly to

s ources , but

corroborated

4

Cannot be

judged

5

Suspected to be

fa lse

PERMISSIONS RESTRICTIONS

HANDLING CODE 1

May be

dis seminated to

other agencies

s igned up to the

same Fi fe

Cons tabulary ISP

without specia l

conditions

2

May be

dis semnated to

other agencies

s igned up to the

s ame Fi fe

Constabulary ISP

with specia l

conditions as

speci fied below.

3

Materia l for the

use of the

receiving agency

only

4

Dis seminate to

speci fided

recipients only

as s peci fied

below

5

Receiving agency

to observe

conditions as

speci fied below

INFORMATION:

SUBJECT:

Annex D

29. Annex E FIFE CONTROLLED DRUG LOCAL INTELLIGENCE NETWORK CONFIDENTIALITY STATEMENT I, ________________________________________________, understand that in the course of my duties I require to access person identifiable data. I understand that the information held for the purpose of the Fife Local Intelligence Network for Controlled Drugs is strictly confidential and that the following rules must be adhered to. Failure to fulfil these obligations will be considered gross misconduct. 1. I will only make use of the data and information for the express purposes specified in the Information Sharing Protocol. 2. I will not divulge information from the supplied data to anyone who is not authorised to receive it. 3. I will not amend any of the data or information provided other than anonymisation for aggregation. 4. I will declare any conflict of interest which arises in accordance with my organisation’s Standing Instructions or Code of Conduct. NAME:………………………………………………………………… POSITION:……………………………………………………………… SIGNATURE: ……………………………………………… DATE:………… (In presence of counter signatory): COUNTER SIGNED ………………………………………. DATE:……………..